The largest database of trusted experimental protocols

Magna lyser homogenizer

Manufactured by Roche
Sourced in Switzerland, France

The MagNA Lyser homogenizer is a compact, high-speed homogenizer designed for efficient cell lysis and sample preparation. It utilizes magnetic beads or ceramic beads to disrupt samples and extract nucleic acids, proteins, or other biomolecules. The homogenizer is suitable for a wide range of sample types, including tissues, cells, and microorganisms.

Automatically generated - may contain errors

15 protocols using magna lyser homogenizer

1

Total RNA Isolation and S1 Nuclease Mapping

Check if the same lab product or an alternative is used in the 5 most similar protocols
For total RNA isolation, tissue was first grinded to powder cooled in liquid nitrogen. The frozen powder was transferred to a MagNA Lyser tube (Roche Applied Science, Indianapolis, IN) filled with 1 ml TRIzol (Invitrogen, Carlsbad, CA) and homogenized immediately by MagNA Lyser homogenizer (Roche Applied Science, Indianapolis, IN). The supernatant was used in RNA isolation following manufacturer’s instructions. For S1 nuclease mapping, appropriate restriction enzyme-digested DNA fragment was labeled at the 5’-end with [γ-32P] ATP and T4 polynucleotide kinase [11 ]. The labeled DNA probe was hybridized to total RNAs prepared from the mouse tissues. The DNA-RNA hybrids that resisted to S1 nuclease digestion were electrophoresed through a 4% polyacrylamide gel containing 7 M urea. Gel was dried and analyzed either by autoradiography or by a phosphorimager (Molecular Dynamics, Sunnyvale, CA).
+ Open protocol
+ Expand
2

Whole-Genome Expression Profiling of Breast Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
For PWBCS, two-color 4X44K Agilent whole genome arrays were performed on a frozen section of cancer-adjacent tissue, with sections on either side used for imaging of cellular composition. Tissue for microarrays was homogenized using a MagnaLyser homogenizer (Roche), and RNA was isolated and quality was checked as described in Troester et al. [15 (link)]. Microarrays were performed as previously described [26 ]. Briefly, Cy3-labeled reference was produced from total RNA from Stratagene Universal Human Reference (spiked 1:1,000 with MCF-7 RNA and 1:1,000 with ME16C RNA to increase expression of breast cancer genes) following amplification with Agilent low RNA input amplification kit. Patient samples were labeled with Cy5. Data were Lowess normalized, and probes with a signal <10 dpi in either channel were excluded as missing. Probes with more than 20% missing data across samples were excluded. In data preprocessing, we (1) eliminated probes without corresponding ENTREZ ID, (2) collapsed duplicate probes by averaging, (3) imputed missing data using k-nearest neighbors (KNN) method with k=10, and (4) median-centered genes. Microarray data are publicly available through the Gene Expression Omnibus (GEO) (GSE49175 [26 ], GSE50939). TCGA data and methods are available at the TCGA Data Portal (https://cga-data.nci.nih.gov).
+ Open protocol
+ Expand
3

Quantifying Bacterial Burden in Infected Animals

Check if the same lab product or an alternative is used in the 5 most similar protocols
To assess bacteremia (blood circulating bacteria) in infected animals, 10 μl of blood was sampled at 1 h, 3 h, 4 h, 22 h, 46 h after infection depending on the experiment and at the time of sacrifice. Serial dilutions of blood were plated on GCB agar plates and incubated overnight at 37°C and in a moist atmosphere containing 5% CO2. Bacterial counts were expressed as colony-forming units (CFU) per ml of blood. To assess the extent of vascular colonization by meningococci (adherent bacteria) following mouse sacrifice at indicated times post-infection, engineered human constructs (implants) or murine skin or the subcutaneous tissue below the implants were collected and placed in 500 μl of Phosphate Buffered Saline (PBS, Invitrogen). Samples were dissociated and homogenized individually using MagNA lyser homogenizer (Roche, France) and serial dilutions of homogenates were plated on GCB plates incubated overnight at 37°C and in a moist atmosphere containing 5% CO2. Bacterial counts were expressed in CFU per implant or murine sample.
+ Open protocol
+ Expand
4

Bacterial viability after homogenization and bead beating

Check if the same lab product or an alternative is used in the 5 most similar protocols
In order to determine the impact of three different methods on viability of planktonic bacteria, suspensions were subjected to homogenization or bead beating for various times.
Staphylococcus aureus and Escherichia coli previously isolated in the Biomaterials-Related Infection laboratory, University of Nottingham, UK, were used for the preparation of bacterial suspensions in tryptic soy broth (TSB, Oxoid, Basingstoke, UK) at a concentration of 105 cfu/mL. Concentration was controlled by light absorbance calibration and plating of serial dilutions.
One hundred microliters of each suspension was added to 1 mL of phosphate-buffered saline (PBS) and treated by either homogenization for two or four cycles (each cycle lasting for 45 s at a speed of 4500 rpm with 45 s between cycles) or bead beating for two or four cycles in the same way as homogenization using 0.1-mm glass beads. The MagNA Lyser homogenizer (Roche, Basel, Switzerland) was used.
One hundred microliters of bacterial suspensions were also added to 0.1% w/v dithiothreitol (DTT, Thermo Fisher Scientific, Vilnius, Lithuania) in sterile water for 5 min before plating to be compared to homogenized samples for four cycles as described above.
One hundred microliters of each of processed and control (unprocessed) bacterial suspension was spread on blood agar plates (Oxoid), and colonies were counted after overnight incubation.
+ Open protocol
+ Expand
5

Immunoprecipitation and Western Blot Analyses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunoprecipitation and western blot analyses were performed as described earlier17 (link). Briefly, livers or lungs from ob/ob mice were homogenized in 1 mL of lysis buffer with a MagNa lyser homogenizer (Roche, Indianapolis, IN). 5 mg of total liver lysates were immunoprecipitated with 10 μl of sepharose-conjugated anti-Akt or phospho Stat3 antibodies and immunoblotted with an anti-phospho Akt or anti-Stat3 rabbit polyclonal antibodies, respectively. Total Akt and Stat3 in the liver lysates (50 μg) were detected using an anti-Akt and Stat3 rabbit polyclonal antibodies, respectively. ERK1/2 phosphorylation studies in HepG2 cells were performed by immunoblotting for phospho ERK1/2 and anti-ERK1/2 with rabbit polyclonal antibodies, as described2 (link). All antibodies were purchased from Cell Signaling (Danvers, MA). mBP3 expression in transfected ob/ob mouse lungs was detected by immunoblot analysis using an anti mouse FGFBP3 rabbit polyclonal antibody (Abgent).
+ Open protocol
+ Expand
6

Gastric Mucosa RNA Extraction and qPCR Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA samples were prepared using the RNeasy Plus Micro Kit (#74034; Qiagen, Hilden, Germany). Briefly, gastric mucosa tissues were homogenized in Buffer RLT Plus using the MagNA Lyser homogenizer (Roche, Mannheim, Germany). The lysates were centrifuged at full speed for 3 min, the supernatant was carefully transferred to a gDNA Eliminator spin column, and RNA was isolated according to the manufacturer’s protocol. mRNA was reverse-transcribed using the High-Capacity RNA-to-cDNA Kit (Applied Biosystems, San Diego, CA, USA), and qPCR was performed using a specific primer and SensiFAST SYBR Lo-ROX Kit (Bioline, Taunton, MA, USA) on a LightCycler 480 System (Roche, Mannheim, Germany). Primer sequences used in this study are listed in Table S1. The relative mRNA expression of each gene was normalized to that of the housekeeping gene (L32) and calculated using the 2−ΔΔCT method.
+ Open protocol
+ Expand
7

Lung Homogenate Plaque Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Vero cells were plated at 2x105 cells per well in 12-well plates and allowed to grow to 90–95% confluency overnight. Superior and middle lung lobes were homogenized in 0.5 mL of media (DMEM + 5% FBS + 1 mM L-glutamine) at 6000 rpm for 40 sec using a Roche MagNA Lyser homogenizer and centrifuged for 1 min at full speed to pellet debris. 50μL of the supernatant was added to 450 μL DMEM + 5% FBS + 1 mM L-glutamine media, and ten-fold serial dilutions were made to create a dilution series of 10−1 to 10−6. 200 μL of each homogenate dilution were added to the plated Vero cells and incubated at 37°C. After 1 h, 2 mL of overlay (50:50 mixture of 2.5% carboxymethylcellulose and 2X alpha MEM + 6% FBS + 2% penicillin/streptomycin + 2% L-glutamine + 2% HEPES) was added to each well, and plates were incubated at 37°C, 5% CO2 for 4 days. 2 mL of 4% paraformaldehyde was added to each well and allowed to fix cells overnight. Following removal of the fixative, wells were stained with 0.25% crystal violet, and visible plaques were counted and averaged between two technical replicate wells. Viral titers were calculated as pfu per lung tissue. The limit of detection (LOD) for the assay was determined to be 12.5 pfu / lung tissue, and samples that yielded no plaques were assigned a value of 6.25, half of the LOD.
+ Open protocol
+ Expand
8

Quantifying Bacteremia and Vascular Colonization

Check if the same lab product or an alternative is used in the 5 most similar protocols
To assess bacteremia (blood circulating bacteria) in infected animals, 10 µl of blood was sampled before infection, 5 min after infection, and at the time of sacrifice. Serial dilutions of blood were plated on GCB agar plates and incubated overnight at 37 °C and in a moist atmosphere containing 5% CO2. Bacterial counts were expressed in colony-forming units (CFU) per ml of blood.
To assess the extent of vascular colonization by meningococci (adherent bacteria) following mouse sacrifice at indicated times post infection, tissue biopsies were collected using a sterile dermatological biopsy puncher (~4 mm2), weighted and placed in 500 µl 1× PBS. Skin biopsies were dissociated and homogenized using MagNA lyser homogenizer (Roche, France) and serial dilutions of skin homogenates were plated on GCB plates and incubated overnight at 37 °C and in a moist atmosphere containing 5% CO2. Bacterial counts were expressed in colony-forming units (CFU) per mg of the skin.
+ Open protocol
+ Expand
9

Quantifying Wound Bacterial Burden

Check if the same lab product or an alternative is used in the 5 most similar protocols
Harvested wound tissues were placed in tubes pre-filled with homogenizer beads (Roche, Indianapolis, IN). After adding 1 mL of PBS, the tubes were homogenized for 90 s at 5000 rpm in a MagnaLYSER homogenizer (Roche, Indianapolis, IN). The homogenate was removed for determination viable counts (500 μl) and for isolating bacterial genomic DNA for determinations of Pseudomonas and total bacterial counts by PCR (200 μl). The viable counts were determined as previously described [3 (link)], and control wounds were similarly assayed to ensure their sterility.
For the determination of total cell counts by PCR, bacterial DNA was isolated from 200 μl of the homogenate (cleared by centrifugation, 3 min at 4°C at 14,000 rpm in an Eppendorf 5417R), using the DNeasy Blood & Tissue Kit (Qiagen, Valencia, CA), according to the manufacturer's instruction. Total P. aeruginosa cell counts were quantified by PCR analysis of the outer membrane lipoprotein gene oprL [42 (link)]. Total bacterial load was quantified by PCR analysis of 16S rDNA [43 (link)]. The primers and probes were synthesized by Applied Biosystems (Carlsbad, CA) and were listed in S3 Table. For these determinations, the standard curve was generated using the genomic DNA that was isolated from mid-log growth phase P. aeruginosa cultures (quantified using the Quant-iT ds DNA BR Assay Kit, Invitrogen).
+ Open protocol
+ Expand
10

Quantitative Expression Analysis of Inflammatory and Neuropeptide Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA extractions, reverse transcription and qPCR were performed according to the manufacturer’s specifications and described by Fröhlich et al. (2016) (link). Hypothalamic tissue samples were homogenized with the MagnaLyser homogenizer (Roche Diagnostics). RNA was extracted using the RNeasy lipid tissue mini kit (Qiagen, Hilden, Germany). Subsequently, RNA concentrations were determined using NanoDrop (Thermo Fisher Scientific, Vienna, Austria), and 2 μg of RNA of each sample was reverse-transcribed in the Mastercycler Gradient (Eppendorf, Hamburg, Germany), using the high capacity cDNA reverse transcription kit (Thermo Fisher Scientific). Afterward, mRNA levels were quantified in triplicates via qPCR using a LightCycler 480® system with TaqMan gene expression assays for IFN-γ (Mm01168134_m1), IL-1β (Mm00434228_m1), IL-6 (Mm00446190_m1), NPY (Mm03048253_m1), and TNF-α (Mm00443258_m1) and with the TaqMan gene expression master mix (Thermo Fisher Scientific). Negative controls without reverse transcriptase added were included for each treatment group. As reference genes (endogenous housekeeping), PPIL3 (Mm00510343_m1), and ACTB (Mm00607939_s1) were used. In order to quantitate target gene levels relative to controls the 2-ΔΔCt method was used, where the mean value of the vehicle treated group was used as calibrator and group differences were expressed as fold changes.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!